Literature DB >> 19716661

A novel brain injury mechanism after intracerebral hemorrhage: the interaction between heme products and the immune system.

Matthew C Loftspring1, Craig Hansen, Joseph F Clark.   

Abstract

In this paper we hypothesize a novel mechanism by which brain injury occurs after intracerebral hemorrhage. We propose the following mechanism: (1) heme that is derived from extravasated erythrocytes is degraded into bilirubin and bilirubin oxidation products (BOXes). (2) Bilirubin and BOXes activate microglia and astrocytes, which are cells with immune functions in the brain. This activation leads to release of cytokines and activation of leukocyte adhesion molecules on the luminal surface of cerebral endothelial cells. (3) Leukocytes then traffic into the brain. (4) Leukocytes, activated glial cells and cytokines contribute to injury processes. We present preliminary data in support of our hypothesis that BOXes activate glia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19716661      PMCID: PMC2787807          DOI: 10.1016/j.mehy.2009.08.002

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  31 in total

Review 1.  Microglia in health and disease.

Authors:  Seung U Kim; Jean de Vellis
Journal:  J Neurosci Res       Date:  2005-08-01       Impact factor: 4.164

2.  Immune pre-activation exacerbates hemorrhagic brain injury in immature mouse brain.

Authors:  Mengzhou Xue; Marc R Del Bigio
Journal:  J Neuroimmunol       Date:  2005-08       Impact factor: 3.478

3.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

4.  Role of NADPH oxidase in the brain injury of intracerebral hemorrhage.

Authors:  Jiping Tang; Jun Liu; Changman Zhou; Dmitry Ostanin; Matthew B Grisham; D Neil Granger; John H Zhang
Journal:  J Neurochem       Date:  2005-07-11       Impact factor: 5.372

Review 5.  NADPH oxidases of the brain: distribution, regulation, and function.

Authors:  David W Infanger; Ram V Sharma; Robin L Davisson
Journal:  Antioxid Redox Signal       Date:  2006 Sep-Oct       Impact factor: 8.401

6.  Bilirubin production and oxidation in CSF of patients with cerebral vasospasm after subarachnoid hemorrhage.

Authors:  Gail J Pyne-Geithman; Chad J Morgan; Kenneth Wagner; Elizabeth M Dulaney; Janice Carrozzella; Daniel S Kanter; Mario Zuccarello; Joseph F Clark
Journal:  J Cereb Blood Flow Metab       Date:  2005-08       Impact factor: 6.200

7.  Tuftsin fragment 1-3 is beneficial when delivered after the induction of intracerebral hemorrhage.

Authors:  Jian Wang; Stella E Tsirka
Journal:  Stroke       Date:  2005-02-03       Impact factor: 7.914

Review 8.  Chemical and biochemical oxidations in spinal fluid after subarachnoid hemorrhage.

Authors:  Joseph F Clark; Matthew Loftspring; William L Wurster; Gail J Pyne-Geithman
Journal:  Front Biosci       Date:  2008-01-01

9.  An in vitro model of aneurysmal subarachnoid hemorrhage: oxidation of unconjugated bilirubin by cytochrome oxidase.

Authors:  Matthew C Loftspring; William L Wurster; Gail J Pyne-Geithman; Joseph F Clark
Journal:  J Neurochem       Date:  2007-06-01       Impact factor: 5.372

10.  Lobar intracerebral hemorrhage model in pigs: rapid edema development in perihematomal white matter.

Authors:  K R Wagner; G Xi; Y Hua; M Kleinholz; G M de Courten-Myers; R E Myers; J P Broderick; T G Brott
Journal:  Stroke       Date:  1996-03       Impact factor: 7.914

View more
  11 in total

1.  Minocycline attenuates photoreceptor degeneration in a mouse model of subretinal hemorrhage microglial: inhibition as a potential therapeutic strategy.

Authors:  Lian Zhao; Wenxin Ma; Robert N Fariss; Wai T Wong
Journal:  Am J Pathol       Date:  2011-07-19       Impact factor: 4.307

2.  Inflammatory Biomarkers and Their Value in Predicting Survival and Outcome among Patients with Spontaneous Intracerebral Haemorrhage.

Authors:  Senthil Kumar Rajapathy; Zamzuri Idris; Regunath Kandasamy; Albert Wong Sii Hieng; Jafri Malin Abdullah
Journal:  Malays J Med Sci       Date:  2017-06-30

3.  Carvacrol protects neuroblastoma SH-SY5Y cells against Fe(2+)-induced apoptosis by suppressing activation of MAPK/JNK-NF-κB signaling pathway.

Authors:  Zhen-wen Cui; Zheng-xing Xie; Bao-feng Wang; Zhi-hong Zhong; Xiao-yan Chen; Yu-hao Sun; Qing-fang Sun; Guo-yuan Yang; Liu-guan Bian
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

4.  Bilirubin and its oxidation products damage brain white matter.

Authors:  Katarina Lakovic; Jinglu Ai; Josephine D'Abbondanza; Asma Tariq; Mohammed Sabri; Abdullah K Alarfaj; Punarjot Vasdev; Robert Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2014-08-27       Impact factor: 6.200

5.  Peripheral leukocyte counts and outcomes after intracerebral hemorrhage.

Authors:  Shruti Agnihotri; Alexandra Czap; Ilene Staff; Gil Fortunato; Louise D McCullough
Journal:  J Neuroinflammation       Date:  2011-11-16       Impact factor: 8.322

Review 6.  Neuroinflammation after intracerebral hemorrhage.

Authors:  Eva Mracsko; Roland Veltkamp
Journal:  Front Cell Neurosci       Date:  2014-11-20       Impact factor: 5.505

7.  Resveratrol protects against ICV collagenase-induced neurobehavioral and biochemical deficits.

Authors:  Navdeep Singh; Yashika Bansal; Ranjana Bhandari; Lovish Marwaha; Raghunath Singh; Kanwaljit Chopra; Anurag Kuhad
Journal:  J Inflamm (Lond)       Date:  2017-06-09       Impact factor: 4.981

Review 8.  Microglial responses after ischemic stroke and intracerebral hemorrhage.

Authors:  Roslyn A Taylor; Lauren H Sansing
Journal:  Clin Dev Immunol       Date:  2013-10-10

Review 9.  To look beyond vasospasm in aneurysmal subarachnoid haemorrhage.

Authors:  Giulia Cossu; Mahmoud Messerer; Mauro Oddo; Roy Thomas Daniel
Journal:  Biomed Res Int       Date:  2014-05-19       Impact factor: 3.411

10.  Bilirubin Oxidation Products and Cerebral Vasoconstriction.

Authors:  Robert M Rapoport
Journal:  Front Pharmacol       Date:  2018-04-27       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.